非小細胞肺癌に対するCDDP・IFX・VP-16併用療法とCBDCA・IFX・VP-16併用療法の無作為比較試験

作者: Ryujiro Suzuki , Kenzo Takagi , Michihiro Hara , Joh Shindoh , Hiroyuki Taniguchi

DOI: 10.2482/HAIGAN.33.383

关键词:

摘要: 進行非小細胞肺癌に対するCDDP・IFX・VP-16併用療法 (PIE療法) とCBDCA・IFX・VP-16併用療法 (CIE療法) を比較検討するために無作為比較試験を行った. 70名の登録があり, 奏効率はPIE群で41.9%, CIE群で27.8%となり, 両群間に有意差を認めなかった.67名の適格例での検討では, median survival timeは, PIE群で7.0ヵ月, CIE群で9.2ヵ月となり, CIE群で有意, に良好であった. また, 副作用として, 血液毒性, 消化器症状がCIE群で有意に少なかった.

参考文章(16)
Frances A. Shepherd, David Stewart, Ellen Warner, Paul E. Goss, Jean Maroun, Karen Paul, Diane Logan, William K. Evans, Jean Latreille, Ifosfamide, cisplatin, and etoposide (ICE) in the treatment of advanced non-small cell lung cancer. Seminars in Oncology. ,vol. 19, pp. 54- 58 ,(1992) , 10.5555/URI:PII:009377549290242S
Jean Klastersky, Jean-Paul Sculier, Hendrik Lacroix, Gérard Dabouis, Gérard Bureau, P Libert, Michel Richez, Pol Ravez, Guy Vandermoten, Jacques Thiriaux, None, A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. Journal of Clinical Oncology. ,vol. 8, pp. 1556- 1562 ,(1990) , 10.1200/JCO.1990.8.9.1556
J Klastersky, J P Sculier, G Bureau, P Libert, P Ravez, G Vandermoten, J Thiriaux, J Lecomte, R Cordier, G Dabouis, Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium. Journal of Clinical Oncology. ,vol. 7, pp. 1087- 1092 ,(1989) , 10.1200/JCO.1989.7.8.1087
P D Bonomi, D M Finkelstein, J C Ruckdeschel, R H Blum, M D Green, B Mason, R Hahn, D C Tormey, J Harris, R Comis, Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group. Journal of Clinical Oncology. ,vol. 7, pp. 1602- 1613 ,(1989) , 10.1200/JCO.1989.7.11.1602
Adriano Paccagnella, Adolfo Favaretto, Alba Brandes, Cristina Ghiotto, Driano Fornasiero, Antonio Volpi, Giovanni Pappagallo, Giuliana Festi, Angiolo Cipriani, Orazio Vinante, Vanna Chiarion-Sileni, Mario V. Fiorentino, Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm Cancer. ,vol. 65, pp. 2631- 2634 ,(1990) , 10.1002/1097-0142(19900615)65:12<2631::AID-CNCR2820651205>3.0.CO;2-Y
J.A Elliott, S Ahmedzai, D Hole, A.J Dorward, R.D Stevenson, S.B Kaye, S.W Banham, B.H.R Stack, K.C Calman, Vindesine and cisplatin combination chemotherapy compared with vindesine as a single agent in the management of non-small cell lung cancer: A randomized study European Journal of Cancer and Clinical Oncology. ,vol. 20, pp. 1025- 1032 ,(1984) , 10.1016/0277-5379(84)90104-4
W.W. ten Bokkel Huinink, M.E.L. van der Burg, A.T. van Oosterom, J.P. Neijt, M. George, J.P. Guastalla, C.H.N. Veenhof, N. Rotmensz, O. Dalesio, J.B. Vermorken, Carboplatin in combination therapy for ovarian cancer Cancer Treatment Reviews. ,vol. 15, pp. 9- 15 ,(1988) , 10.1016/0305-7372(88)90030-8
S. Niitamo-Korhonen, P. Holsti, L.R. Holsti, S. Pyrhönen, K. Mattson, A comparison of cis-platinum-vindesine and cis-platinum-etoposide combined with radiotherapy for previously untreated localized inoperable non-small cell lung cancer. European Journal of Cancer and Clinical Oncology. ,vol. 25, pp. 1039- 1043 ,(1989) , 10.1016/0277-5379(89)90385-4
E. Wiltshaw, Ovarian trials at the Royal Marsden. Cancer Treatment Reviews. ,vol. 12, pp. 67- 71 ,(1985) , 10.1016/0305-7372(85)90020-9